Alimera Sciences, Inc. Discusses Its 2021 Global Expansion Strategy with The Stock Day Podcast

The Stock Day Podcast welcomed Alimera Sciences, Inc. (ALIM)(“the Company”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. President and CEO of the Company, Rick Eiswirth, joined Stock Day host Everett Jolly.